Advertisement

Association of haplotype and linkage disequilibrium of PARP1 polymorphisms rs1136410, rs1805405 and rs3219088 with gallbladder cancer

Published:December 27, 2022DOI:https://doi.org/10.1016/j.dld.2022.12.006

      Abstract

      Background

      Previously, we have reported that PARP1 rs1136410 is significantly associated with increased the risk of gallbladder cancer.

      Aim

      We aimed to investigate the association of PARP1 rs1805405 and rs3219088 polymorphisms with risk of GBC and also association of the haplotype and combined effect of PARP1 SNPs (rs1805405 G/A, rs3219088 G/T and rs1136410 A/G). We have also investigated the expression profile of PARP1 and its correlation with polymorphisms, clinical parameters and overall survival.

      Methods

      PARP1 polymorphisms were genotyped by PCR-RFLP and the expression profile of PARP1 at mRNA level was analyzed by semi-quantitative PCR. Overall survival was analyzed using Kaplan-Meier plot and Cox-regression analysis.

      Results

      Haplotype analysis of the PARP1 polymorphisms revealed that AGG, AAG and GGT haplotypes are significantly associated with decreased risk of GBC, while AAT, AGT, GGG and GAG haplotypes are significantly associated with increased risk of GBC. Patients with T1+T2 and treated with chemotherapy having risk genotypes of rs1805405 have decreased overall survival. Upregulation of PARP1 is significantly associated with longer overall survival in patients with GBC with different clinical parameters. SNPs rs1136410 and rs1805405 genotypes are significantly associated with PARP1 expression.

      Conclusion

      Haplotype analysis suggests that PARP1 may have a potential role in gallbladder carcinogenesis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Huang W.Y.
        • Gao Y.T.
        • Rashid A.
        • et al.
        Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China.
        Carcinogenesis. 2008; 29: 100-105
        • Sanada M.
        • Suzuki T.
        • Shih L.Y.
        • et al.
        Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
        Nature. 2009; 460: 904-908
        • DE Angelis P.M.
        • Dorg L.
        • Pham S.
        • et al.
        DNA repair protein expression and oxidative/nitrosative stress in ulcerative colitis and sporadic colorectal cancer.
        Anticancer Res. 2021; 41: 3261-3270
        • Afzal H.
        • Yousaf S.
        • Rahman F.
        • et al.
        PARP1: a potential biomarker for gastric cancer.
        Pathol Res Pract. 2019; 215152472
        • Anjali K.
        • Singh D.
        • Kumar P.
        • et al.
        PARP1 rs1136410 (A/G) polymorphism is associated with early age of onset of gallbladder cancer.
        Eur J Cancer Prev. 2022; 31: 311-317
        • Anjali K.
        • Kumar T.
        • Kumar P.
        • et al.
        Association of nonsynonymous SNPs of nucleotide excision repair genes ERCC4 rs1800067 (G/A) and ERCC5 rs17655 (G/C) as predisposing risk factors for gallbladder cancer.
        Dig Liver Dis. 2022; ([published online ahead of print, 2022 Jun 29]) (S1590-8658(22)00552-7)
        • Shi Y.Y.
        • He L
        SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.
        Cell Res. 2005; 15: 97-98
        • Madhusudan S.
        • Middleton M.R
        The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer.
        Cancer Treat Rev. 2005; 31: 603-617
        • Chen H.
        • Pu X.Y.
        • Zhang R.P.
        • et al.
        Association of common SNP rs1136410 in PARP1 gene with the susceptibility to male infertility with oligospermia.
        J Assist Reprod Genet. 2014; 31: 1391-1395
        • Durocher F.
        • Labrie Y.
        • Ouellette G.
        • et al.
        Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer.
        J Hum Genet. 2007; 52: 963-977
        • Abecassis I.
        • Sedgewick A.J.
        • Romkes M.
        • et al.
        PARP1 rs1805407 increases sensitivity to parp1 inhibitors in cancer cells suggesting an improved therapeutic strategy.
        Sci Rep. 2019; 9: 3309
        • Ramezani S.
        • Sharafshah A.
        • Mirzanejad L.
        • Hadavi M.
        • et al.
        Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
        Gene. 2019; 712143954
        • Jin J.
        • Robeson H.
        • Fagan P.
        • et al.
        Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes.
        PLoS ONE. 2020; 15e0243509
        • Jin X.M.
        • Kim H.N.
        • Lee I.K.
        • et al.
        PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.
        BMC Med Genet. 2010; 11: 38
        • Shiokawa M.
        • Masutani M.
        • Fujihara H.
        • et al.
        Genetic alteration of poly(ADP-ribose) polymerase-1 in human germ cell tumors.
        Jpn J Clin Oncol. 2005; 35: 97-102
        • Fisher S.B.
        • Fisher K.E.
        • Patel S.H.
        • et al.
        Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy.
        Cancer. 2013; 119: 4
        • Singh N.
        • Kazim S.N.
        • Sultana R.
        • et al.
        Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
        Free Radic Res. 2019; 53: 473-485
        • Sato K.
        • Kitajima Y.
        • Koga Y.
        • et al.
        The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in gallbladder carcinoma cells.
        Anticancer Res. 2005; 25: 4021-4028
        • Bian R.
        • Dang W.
        • Song X.
        • et al.
        Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
        Int J Biol Sci. 2021; 17: 2167-2180
        • Quinonero F.
        • Cepero A.
        • Urbano D.
        • et al.
        Identification of PARP-1 in cancer stem cells of gastrointestinal cancers: a preliminary study.
        J Biosci. 2021; 46: 6
        • Bao R.
        • Shu Y.
        • Wu X.
        • et al.
        Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
        BMC Cancer. 2014; 14: 217
        • Yang Y.
        • Li X.
        • Hao L.
        • et al.
        The diagnostic value of DNA repair gene in breast cancer metastasis.
        Sci Rep. 2020; 10: 19626
        • Li X.
        • Li C.
        • Jin J.
        • et al.
        High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects.
        E Bio Med. 2018; 38: 47-56
        • Xie K.J.
        • HE He
        • Sun A.J.
        • et al.
        Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
        Asian Pac J Cancer Prev. 2014; 15: 2591-2596
        • Veskimäe K.
        • Staff S.
        • Grönholm A.
        • et al.
        Assessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry.
        Tumour Biol. 2016; 37: 11991-11999
        • Akbar N.
        • Yaseen T.
        • Muhammad A.
        • et al.
        A tertiary care center's experience with clinicopathological characteristics of gallbladder carcinoma in our population.
        Euroasian J Hepatogastroenterol. 2022; 12: 35-39
        • Dutta U.
        • Bush N.
        • Kalsi D.
        • et al.
        Epidemiology of gallbladder cancer in India.
        Chin Clin Oncol. 2019; 8: 33